Department of Epidemiology and Biostatistics, Medical University of Lodz, Lodz, Poland
References
[1] Maniecka-Bryła I., Pikala M., Bryła M., Life years lost due to cardiovascular diseases. Kardiol. Pol. 2013, 71, 293–300
[2] Maniecka-Bryła I., Pikala M., Bryła M., Health inequalities among rural and urban inhabitants of Łódź province, Poland. Ann. Agric. Environ. Med. 2012, 19, 723–731
[3] Maniecka-Bryła I, Maciak-Andrzejewska A, Bryła M, Bojar I, An assessment of health effects of a cardiological prophylaxis programme in a local community with the use of the SCORE algorithm. Ann. Agric. Environ. Med. 2013. 20,794–799
[4] Mckee M., Perry I., Ischaemic heart disease - more than just lipids. Eur. J. Public Health 2002, 12, 241–242 http://dx.doi.org/10.1093/eurpub/12.4.241[Crossref]
[5] Bryła M., Maciak-Andrzejewska A., Maniecka-Bryła I., Częstość wybranych czynników ryzyka chorób układu krążenia w zależności od charakteru wykonywanej pracy. Med. Pr. 2013, 64, 307–315
[6] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002, 106, 3143–3421
[7] Pająk A., Wiercińska E., Polakowska M., Kozakiewicz K., Kaczmarczyk-Chałas K., Tykarski A. i in., Rozpowszechnienie dyslipidemii u mężczyzn i kobiet w wieku 20–74 lata w Polsce. Wyniki programu WOBASZ. Kardiol. Pol. 2005, 63,supl. 4, 1–4
[8] Zdrojewski T., Bandosz P., Szpakowski P. Konarski R., Manikowski A., Wołkiewicz E. i in., Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol. Pol. 2004, 61,supl. 1, 1–26
[9] Mastej M., Jóźwiak J., Lukas W. Piwowarska W., Tykarski A., Orzechowski M., Ocena i porównanie parametrów lipidogramu w zależności od płci oraz wskaźnika masy ciała BMI. Kardiol. Pol. 2006, 64, supl. 2, 153–160
[10] Ministry of Health - National Health Plan for years 2004–2013. Warsaw, Poland, 2003; 262–263
[11] Narodowy Program Zdrowia 2007–2015, Ministerstwo Zdrowia, Warszawa 2007
[12] Lorezno C., Williams K., Hunt K. Haffner S.M., The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diabetes Care, 2007, 30, 8–13 http://dx.doi.org/10.2337/dc06-1414[Crossref][WoS]
[13] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation, 2002, 106, 3143
[14] Arnett D.K., Jacobs D.R., Luepker R.V., Blackburn H,, Armstrong C, Claas S.A., Twenty-Year Trends in Serum Cholesterol, Hypercholesterolemia, and Cholesterol Medication Use: The Minnesota Heart Survey, 1980–1982 to 2000–2002. Circulation 2005, 112, 3884–3891 http://dx.doi.org/10.1161/CIRCULATIONAHA.105.549857[Crossref]
[15] Rysz J., Banach M., Stolarek R., Irzmański R., Markuszewski L., Wilk R., The lipid disorders therapy in overweight patients. Arch. Med. Sci. 2005, 1, 241–245
[16] Batic-Mujanovic O., Beganlic A., Salihefendic N. Pranjic N., Kusljugic Z., Influence of smoking on serum lipid and lipoprotein levels among family medicine patients. Med. Arh. 2008, 62, 264–267
[17] Nakamura K., Barzi F., Huxley R., Lam T.H., Suh I., Woo J. et. al., Asia Pacific Cohort Studies Collaboration: Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases? Heart, 2009, 95, 909–916 http://dx.doi.org/10.1136/hrt.2008.147066[Crossref]
[18] Noguchi Y., Fukui T., The effects of cessation from cigarette smoking on the lipid and lipoprotein pro- files: a meta-analysis. Prev. Med. 2003. 37. 283–90 http://dx.doi.org/10.1016/S0091-7435(03)00110-5[Crossref]
[19] Piper M.E., Johnson H.M., Fiore M.C., Baker T.B., Stein J.H., Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am. Heart J. 2011, 161, 145–151 http://dx.doi.org/10.1016/j.ahj.2010.09.023[Crossref]
[20] De Miguel-Díez J., Carrasco-Garrido P., Rejas-Gutierrez J. Martín-Centeno A., Gobartt-Vázquez E., Hernandez-Barrera V., et al., The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings. Cardiovascular Disorders, 2010, 10, 8–17 http://dx.doi.org/10.1186/1471-2261-10-8[Crossref]
[21] European Hearth Health Charter - European Society of Cardiology and the European Heart Network; Brussels 2007: 10
[22] Kirkwood L., Aldujaili E., Drummond S., Effects of advice on dietary intake and/or physical activity on body composition, blood lipids and insulin resistance following a low-fat, sucrose-containing, highcarbohydrate, energy-restricted diet. Int. J. Food Sci. Nutr. 2007, 58, 383–397 http://dx.doi.org/10.1080/09637480701252336[WoS][Crossref]
[23] Ainslie P.N., Reilly T., Maclaren D.P., Campbell I.T., Changes in plasma lipids and lipoproteins following 10-days of prolonged walking: influence of age and relationship to physical activity level. Ergonomics 2005. 48, 1352–1364 http://dx.doi.org/10.1080/00140130500101130[Crossref]
[24] Skoumas J., Pitsavos C., Panagiotakos D.B., Chrysohoou C., Zeimbekis A., Papaioannou I., et al., Physical activity, high density lipoprotein cholesterol and other lipids levels, in men and women from the ATTICA study. Lipids in Health and Disease, 2003, 2, 3–11 http://dx.doi.org/10.1186/1476-511X-2-3[Crossref]
[25] Pelletier D.L., Baker P.T., Physical activity and plasma total- and HDL-cholesterol levels in Western Samoan men. AJCN 1987, 46, 577–585
[26] Gordon L., Ragoobirsingh D., Morrison E., McGrowder D., Choo-Kang E., Martorell E., Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica. Arch. Med. Sci. 2010, 6, 701–708 http://dx.doi.org/10.5114/aoms.2010.17084